About this trial
The primary objective of this study is to rigorously evaluate the effectiveness of a Food is Medicine (FIM) intervention using objective biomarkers and to determine the role of nutritional monitoring on the impact and sustainability of integrating nutrition supports into primary care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
adults (18 years or older)
at risk for food insecurity (affirmative response to one or more questions on the Huger Vital Signs
at risk or experiencing a nutrition-sensitive chronic conditions (e.g., obesity, type 2 diabetes, MASLD, hypertension, etc.)
able to read and write in English or Spanish
Disqualifiers
planned relocation within the study window
currently pregnant or plans to become pregnant within the study window
unable to provide informed consent
Trial design
Parallel
Treatments tested in this trial
Bite-sized Biomarkers: Skin carotenoid scores
BehavioralIn this intervention, participants will be randomized to either receive or be masked to additional information on their nutritional status by measuring skin carotenoid scores as a proxy of fruit and vegetable intake to see if knowledge of status at baseline leads to more dietary behavior change.
Treatment groups
Trial outcomes
Primary outcomes
Skin carotenoid scores
Change in skin carotenoid scores measured using pressure-mediated reflection spectroscopy (Veggie Meter)
Secondary outcomes
Dietary Intake
Dietary intake will be calculated using the Healthy Eating Index (HEI)-2020
Depression
Symptoms of depression will be measured using the 9-item Patient Health Questionnaire (PHQ-9)
Anxiety
Symptoms of anxiety will be measured using the 7-item Generalized Anxiety Disorder (GAD-7).
Food security status
Food security status will be measured using the USDA Adult Food Security Survey Module
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stanford University
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: